These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 18285314
1. A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo. Shubar HM, Mayer JP, Hopfenmüller W, Liesenfeld O. J Antimicrob Chemother; 2008 May; 61(5):1110-9. PubMed ID: 18285314 [Abstract] [Full Text] [Related]
2. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations. Ling Y, Sahota G, Odeh S, Chan JM, Araujo FG, Moreno SN, Oldfield E. J Med Chem; 2005 May 05; 48(9):3130-40. PubMed ID: 15857119 [Abstract] [Full Text] [Related]
3. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo. de Oliveira TC, Silva DA, Rostkowska C, Béla SR, Ferro EA, Magalhães PM, Mineo JR. Exp Parasitol; 2009 Jul 05; 122(3):233-41. PubMed ID: 19389400 [Abstract] [Full Text] [Related]
5. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model. Martins-Duarte ES, Lemgruber L, de Souza W, Vommaro RC. Exp Parasitol; 2010 Apr 05; 124(4):466-9. PubMed ID: 20045696 [Abstract] [Full Text] [Related]
6. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine. Ferreira RA, Oliveira AB, Ribeiro MF, Tafuri WL, Vitor RW. Exp Parasitol; 2006 Jun 05; 113(2):125-9. PubMed ID: 16458300 [Abstract] [Full Text] [Related]
7. Synthesis and evaluation of 4-acyl-2-thiazolylhydrazone derivatives for anti-Toxoplasma efficacy in vitro. Chimenti F, Bizzarri B, Bolasco A, Secci D, Chimenti P, Carradori S, Granese A, Rivanera D, Frishberg N, Bordón C, Jones-Brando L. J Med Chem; 2009 Aug 13; 52(15):4574-7. PubMed ID: 19618935 [Abstract] [Full Text] [Related]
10. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo. Zhang X, Jin L, Cui Z, Zhang C, Wu X, Park H, Quan H, Jin C. Exp Parasitol; 2016 Jun 13; 165():95-102. PubMed ID: 26993085 [Abstract] [Full Text] [Related]
17. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Mui EJ, Jacobus D, Milhous WK, Schiehser G, Hsu H, Roberts CW, Kirisits MJ, McLeod R. Antimicrob Agents Chemother; 2005 Aug 15; 49(8):3463-7. PubMed ID: 16048961 [Abstract] [Full Text] [Related]
18. In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites. Szajnman SH, Galaka T, Li ZH, Li C, Howell NM, Chao MN, Striepen B, Muralidharan V, Moreno SN, Rodriguez JB. Antimicrob Agents Chemother; 2017 Feb 15; 61(2):. PubMed ID: 27895021 [Abstract] [Full Text] [Related]
19. Anti-Toxoplasma gondii activity of GAS in vitro. Chen SX, Wu L, Jiang XG, Feng YY, Cao JP. J Ethnopharmacol; 2008 Aug 13; 118(3):503-7. PubMed ID: 18602775 [Abstract] [Full Text] [Related]
20. Two 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii. Khan AA, Nasr M, Araujo FG. Antimicrob Agents Chemother; 1998 Sep 13; 42(9):2284-9. PubMed ID: 9736550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]